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An Anesthesia-Based Quality Improvement Initiative to Decrease Opioid Administration via
Esmolol Administration
Fredrick J. Hanna, BSN, SRNA
Background: Laryngoscopy and endotracheal intubation are routine procedures that occur
within the surgical setting. Fentanyl is currently administered for attenuating the hemodynamic
response to intubation. Opioid-sparing alternatives have been identified with aims of improving
patient outcomes, such as esmolol. Purpose: The project’s purpose was designed to improve
anesthesia provider familiarity, perception, and consideration of esmolol as a non-narcotic
alternative for attenuating the hemodynamic response to intubation and prompt an increase of
esmolol administration within this setting. Interventions: Surveys were conducted before and
after an educational in-service, offered to anesthesia providers, demonstrating esmolol as an
efficacious alternative to fentanyl. Additionally, an audit was completed identifying esmolol
administration rates during the induction phase of the anesthetic. Methods: Certified registered
nurse anesthetists (CRNAs) and anesthesiologists were asked to complete pre- and posteducation surveys. These surveys consisted of seven Likert-scale responses, two multiple choice
questions and one open-text question. An audit was completed to determine if education
increased provider utilization of non-narcotic alternatives clinically. A statistical analysis was
performed comparing pre-and post- survey and audit results. Results: The in-service and
corresponding surveys were completed by 16 anesthesia providers. Comparing mean responses
between pre- and post-survey Likert-scale responses, four of the seven questions regarding
esmolol as an alternative to fentanyl and perceived barriers to use yielded improved scores. The
mean comparison of correctness of two knowledge-based questions also improved. Respondents
perceived barriers to implementing esmolol within this clinical setting included need for further
education, cultural pushback, and concern for adverse outcomes of esmolol use. The audit of
esmolol administration rates did not yield any statistically significant findings. Conclusion:
After implementation of an educational in-service, anesthesia providers knowledge,
understanding, familiarity and acceptance of esmolol use for attenuating the hemodynamic
response to laryngoscopy and endotracheal intubation improved. Despite this improvement,
practitioners lacked the translation of the learnings into practice. Continued barriers exist when
implementing such narcotic sparing techniques and need to be further addressed.
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An Anesthesia-Based Quality Improvement Initiative to Decrease Opioid Administration
via Esmolol Administration
Laryngoscopy and endotracheal intubation are routine procedures that occur within the
surgical setting. These procedures often stimulate a sympathetic response with resultant
hemodynamic changes including tachycardia, hypertension, and dysrhythmias (Varma et al.,
2015). Fentanyl, a short-acting opioid, is currently administered as a common treatment for
attenuating the hemodynamic response to intubation (Casserly & Alexander, 2020). Increased
dosages of fentanyl perioperatively are associated with adverse outcomes including hypercapnia
and postoperative respiratory complications (Friedrich et al., 2019). Opioid-sparing alternatives
have been identified with aims of improving patient outcomes. Esmolol, a rapid acting betablocker (Fayad, 2019), has been considered one such alternative and proven efficacious in
treating resultant hemodynamics following laryngoscopy and intubation when compared to
fentanyl use (Bostan & Eroglu, 2012; Prakash et al., 2019; Varma et al., 2015). This Doctor of
Nursing Practice (DNP) Project was designed to improve anesthesia provider familiarity,
perception, and consideration of esmolol as a non-narcotic alternative for attenuation of the
hemodynamic response to intubation and prompt an increase of esmolol administration within
this setting.
Background
Problem Description
With more than 49 million anesthetics being administered annually within the United
States, healthcare providers must ensure efficacious use of clinical tools at their disposal (Larson,
2019). Laryngoscopy and endotracheal intubation precipitate a hemodynamic response linked to
undesired clinical outcomes including longer intensive care unit (ICU) stay, worsening of
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cerebral edema (Cheng et al., 2013), and myocardial ischemia (Edwards et al., 1994).
Administration of fentanyl and other narcotics assist in attenuating hemodynamic responses but
have associated adverse outcomes including respiratory depression, chest wall rigidity, delayed
postoperative emergence, an increased propensity for ileus, and the potential for the development
or reoccurrence of addictive behavior (Casserly & Alexander, 2020). Despite fentanyl
administration, studies have demonstrated that resultant tachycardia and hypertension remain
(Varma et al., 2015). A study by Varma et al. (2015) reported a 26.2% increase in heart rate and
a 12.9% increase in blood pressure from baseline in participants who received fentanyl prior to
intubation. These pitfalls with fentanyl have promoted identification of a non-narcotic substitute
for utilization. Esmolol has been identified as one such substitute, proving efficacious in
attenuating hemodynamic response while minimizing adverse outcomes like those associated
with fentanyl administration (Varma et al., 2015).
According to the Agency for Healthcare Research and Quality (AHRQ), in 2014 a total
of 17.2 million hospital visits were related to surgical procedures within the United States
(Mathias, 2017). The rate at which surgeries and anesthetic procedures are conducted annually is
apparent and ever-growing. Safe and effective care is a standard among healthcare providers and
an expectation for patients. Adverse outcomes could arise from components of what can be
considered minor surgical procedures, including the practice of laryngoscopy and endotracheal
intubation.
The sympathetic response to intubation is profound, with an observed 51.3% rise in
systolic blood pressure from baseline in some instances (Ajuzieogu et al., 2009). Patients arrive
to the operating room with an array of comorbidities including ischemic heart disease, arterial
insufficiency, myocardial dysfunction, elevated intraocular pressure, and traumatic brain injuries,
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all which tachycardia and hypertension may prove detrimental (Divatia & Bhowmick, 2005).
Additionally, studies have demonstrated that patients with a history of traumatic brain injuries
who experience a hypertensive response to intubation have been identified as having nearly three
times the likelihood of developing adverse outcomes (Cheng et al., 2013). By diminishing the
severity of hemodynamic changes following direct laryngoscopy and endotracheal intubation,
providers directly aid in preventing such adverse outcomes.
Minimization of narcotic administration has become a national agenda since the opioid
epidemic was declared a public health emergency by the U.S. Government in 2017 (Jones et al.,
2018). The prevalence of drug abuse is growing within the United States. In 2018, The Center
for Disease Control and Prevention (CDC) reported West Virginia as the state with the highest
overdose death rate in America, with 51.5 overdose deaths per 100,000 persons (CDC, 2020a).
Within the United States, 11.2% of persons over the age of 12 have used illicit drugs within the
past month (CDC, 2020b). These statistics highlight the importance for implementing opioidsparing techniques. Research has demonstrated that non-narcotic treatment proves efficacious in
various clinical settings and employing such alternatives will assist in treating this opioid crisis
(Ugur et al, 2017).
Despite identification of safe and efficacious alternatives to narcotics within practice,
barriers for adopting these alternative modalities exist among anesthesia providers, including
both certified registered nurse anesthetists (CRNA) and anesthesiologists. Fentanyl, first used as
an opioid intraoperatively in the 1960’s, has become the most commonly administered
intravenous analgesic in the United States (Stanley, 2014). This robust history of narcotic-based
anesthesia practice makes adoption of newly developed non-narcotic methods of anesthesia
delivery difficult. Barriers of utilizing such alternatives among CRNAs include a belief in opioid
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superiority, limited experience with potential alternatives, and limited opioid-alternative
resources (Velasco et al., 2019). Addressing these barriers will offer an increased potential for
acceptance and implementation of current evidence-based practice.
Problem Statement
Narcotics are commonly administered to minimize the hemodynamic response to
intubation. In attempts to limit opioid use, esmolol has been recognized as an advisable
alternative to narcotics. Barriers to implementation of narcotic sparing techniques exist among
anesthesia providers. Improving familiarity and perception of esmolol minimized barriers and
increase use of esmolol for attenuation of the hemodynamic response to laryngoscopy and
endotracheal intubation.
Literature Review and Synthesis
A clinical question was developed using the patient population, intervention, comparison,
and outcome (PICO) format to yield relevant evidence (Melnyk & Fineout-Overholt, 2019). The
PICO question used to identify current literature and guide project implementation is as follows:
In anesthesia providers, does an educational in-service regarding the efficacy of esmolol without
concurrent narcotic administration to treat the hemodynamic response to laryngoscopy and
endotracheal intubation improve perception and familiarity of esmolol and prompt consideration
of this non-narcotic alternative? A literature search was conducted to discover and evaluate
developed research regarding the efficaciousness of esmolol in attenuating hemodynamic
responses secondary to direct laryngoscopy and endotracheal intubation and identified barriers or
facilitators for adoption of opioid sparing techniques. Literature determining efficacy of esmolol
offers recommendations for anesthesia providers and direct future treatment to optimize patient’s
clinical outcomes. The findings of this literature search were used to assist in understanding
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where current knowledge stands, as well as to develop additional methods for project
implementation and measurement of outcomes.
Search Strategy
Formal databases were utilized to discover relevant articles focused on specific study
designs. These include EbscoHost, Google Scholar and PubMed, all of which were accessible
through West Virginia University’s (WVU) online database. A number of databases were
employed in order to optimize the number of discoverable articles for this literature synthesis.
Specific key words used to identify relevant studies included- “esmolol”, “fentanyl”,
“laryngoscopy”, “hemodynamics”, “endotracheal intubation”, “intubation”, “barriers”, “narcotic
sparing”, “opioid sparing” and “alternatives”. Search limitations were applied, including dates of
publication between 2005 and 2020, full text attached to respondent studies and published in the
English language.
When selecting literature for synthesis, certain exclusion criteria were applied. Exclusion
criteria when comparing esmolol and fentanyl efficacy included research conducted prior to
2005, use of video assisted laryngoscopy techniques, emergent intubations, and methods using
continuous infusion of study drugs rather than bolus intravenous administration. Studies were
considered appropriate for synthesis if additional medications were utilized within the study
design- such as lidocaine- as long as a comparison of outcomes was made between fentanyl and
esmolol administration independently. Literature identifying barriers and facilitators to
implementing opioid sparing techniques were excluded if barriers or facilitators were not within
the perioperative setting and not specific to opioid sparing techniques. Articles were considered
relevant if search terms were within resultant title of studies.
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After applying search terms, and before application of exclusion or inclusion criteria, 129
articles were yielded. After inclusion/exclusion criteria were applied, 20 applicable studies were
identified. After removing duplicate studies among the various databases nine relevant articles
were identified including: six randomized control trials (RCTs) comparing efficacy of esmolol
and fentanyl, one mixed-method and two qualitative studies demonstrating barriers/facilitators to
practice change.
Critical Appraisal of Literature
According to Melnyk & Fineout-Overholt (2019), RCTs are categorized as Class B
evidence and recommendations can be made based upon a single randomized or non-randomized
controlled trial. Additionally, all six RCTs were appraised using the Scottish Intercollegiate
Guidelines Network (SIGN) critical appraisal tool for controlled trials (2007). The two
qualitative studies and one mixed methods study were graded according to Melnyk & FineoutOverholt (2019) as Level 6 Evidence, being single descriptive studies. A summary of specific
components of each individual study including purpose, sample description, methods, variable,
results, strengths, and weaknesses are presented in Table 1.
Similarities among the six RCTs included project methods, design, population, dependent
and independent variables, and outcomes. Common characteristics among selected study
participants were as follows: patients age (ranging from 18 to 65 years of age), American Society
of Anesthesiologists (ASA) Grade I or II classifying severity and prevalence of comorbidities
(ASA, 2019), non-emergent cases, requiring endotracheal intubation. Exclusion criteria for
patient participation within project design among all six studies included the following: history
of cardiovascular/respiratory disease, prescribed antihypertensives, and anticipated difficult
intubation. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and
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mean arterial pressure (MAP) were recorded at regular intervals among all six of the identified
studies (Bostan & Eroglu, 2012; Gupta & Tank, 2011; Prakash et al., 2019; Ugur et al., 2007;
Vaishnav & Chaudhari, 2015; Varma et al., 2015). Rate pressure product (RPP) was additionally
calculated as a clinical indicator of hemodynamic response, as defined by SBP x HR/100 (Gupta
& Tank, 2011; Ugur et al., 2007; Vaishnav & Chaudhari, 2015). Rate pressure product reflects
overall myocardial oxygen demand and myocardial perfusion (Ansari et al., 2012). Statistically
significant findings within studies are reflected by a p-value equal to or less than 0.05.
Bostan & Eroglu (2012) developed a double-blind RCT comparing the efficacy of
esmolol, fentanyl, and lidocaine in preventing a hemodynamic response to laryngoscopy and
intubation. The study included 120 patients undergoing a variety of surgical cases requiring
general anesthesia. Patients were randomly divided into four equal groups. The control group
received normal saline (10 cc), while experimental groups received either fentanyl (1mcg/kg),
esmolol (1 mg/kg) or lidocaine (1 mg/kg) prior to laryngoscopy and intubation. Blood pressure
and HR were recorded at regular intervals from baseline to ten minutes after intubation.
Following intubation, HR, SBP, and DBP were significantly lower in the study groups compared
to the control group (p<0.01) at all time intervals. Esmolol proved more efficacious than
lidocaine and fentanyl at treating SBP and DBP at one, three-, and five-minutes post-intubation
(p<0.05). Authors conclude that lidocaine, esmolol, and fentanyl all prove successful in
decreasing the hemodynamic response to laryngoscopy and intubation, with esmolol proving
slightly more effective.
Similarly, to Bostan & Eroglu (2012), the RCT developed by Ugur et al. (2017) identified
cardiovascular responses to laryngoscopy and intubation following administration of esmolol,
fentanyl, and lidocaine. This randomized-double blind study was developed alongside 120
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patients undergoing a variety of surgical procedures requiring general anesthesia. Participants
were randomized into four equal groups, assigned to receive esmolol (1.5 mg/kg), fentanyl (1
mcg/kg), lidocaine (1.5 mg/kg) or dextrose (5 cc) as the control group, two minutes prior to
intubation. Heart rate, MAP, and RPP were recorded pre- and post- anesthesia, immediately
following intubation, and one, three, five, seven and ten minutes thereafter. An increase in HR
immediately following intubation was observed in all groups, excluding the esmolol group. Only
the fentanyl group was found to have a decrease in MAP following intubation (p<0.0083).
Calculated RPP was lower among the esmolol group three minutes after intubation (p<0.0083),
while lower among the fentanyl group ten minutes following intubation (p<0.0083). Authors
conclude the study by recommending administration of esmolol (1.5 mg/kg) two minutes prior to
laryngoscopy and intubation to prevent a significant increase in HR and RPP.
A comparative RCT developed by Gupta and Tank (2011) identified efficacy of esmolol
and fentanyl within the same setting. Ninety patients were divided into three equal groups,
receiving either normal saline (10 cc), esmolol (2 mg/kg), or fentanyl (2 mcg/kg) three minutes
prior to laryngoscopy. Vitals signs were recorded at regular intervals including HR, SBP, DBP,
MAP and RPP. Following intubation, no significant rise in HR (p<0.001) or SBP was observed
within the esmolol group. A significant increase in RPP was not observed in the esmolol group
(p<0.001) but was apparent in the fentanyl and normal saline groups. Authors conclude that both
esmolol (2 mg/kg) and fentanyl (2 mcg/kg) are successful in treating the hemodynamic response
to intubation but esmolol possesses greater consistency among various time intervals.
Prakash et al. (2019) sought to observe the severity of hemodynamic responses to
intubation following esmolol and fentanyl use in patients undergoing elective orthopedic,
gynecological, general, neurological, and ear, nose, and throat (ENT) surgeries. Patients were
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randomly assigned into two equal groups. Study group I (n=30 patients) received esmolol (2
mg/kg) three minutes prior to laryngoscopy and endotracheal intubation. Study group II (n=30
patients) received fentanyl (2mcg/kg) five minutes before laryngoscopy and intubation. Authors
elected for differing times of medication administration due to pharmacokinetic considerations of
both medications. Group I demonstrated a significantly lower heart rate at one, three-, and tenminutes post-intubation, when compared to group II (p<0.001). Systolic blood pressure, DBP,
and MAP were all lower in group I compared to group II at one- and three-minutes following
intubation. Authors conclude that 2 mg/kg of esmolol provides greater efficacy than 2 mcg/kg of
fentanyl and recommends the use of esmolol three minutes prior to laryngoscopy to attenuate
hemodynamics following intubation.
The double-blind, RCT developed by Vaishnav, and Chaudhari (2015) assessed the
sympathetic response following administration of fentanyl and esmolol with dosages mirroring
the research conducted by Prakash et al. (2019). One hundred patients undergoing elective
surgical procedures were included within the study design. Fifty participants were randomly
assigned to group “E”, receiving 2 mg/kg of esmolol, or group “F”, receiving 2 mcg/kg of
fentanyl. Differing from the methods of Prakash et al. (2019), both medications were
administered three minutes prior to intubation. Heart rate, SBP, DBP and MAP were recorded at
baseline, immediately following study drug administration, and every minute for the first ten
minutes post intubation. Group E demonstrated a lower HR than group F from one to five
minutes (p=0.0001), and a lower SBP than group F at one minute (p<0.05) following intubation.
Rate pressure product was lower (p<0.05) among group E throughout all ten minutes following
intubation. Vaishnav and Chaudhari (2015) conclude that esmolol provides greater reliability and
consistency than fentanyl in attenuating the response to laryngoscopy and intubation.
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Lastly, Varma et al. (2015) developed an RCT with methods aimed at determining
superiority among fentanyl or esmolol for attenuating cardiovascular responses to intubation.
Ninety adult patients were randomly divided among three equal groups to receive either no
medication prior to intubation as the control group, esmolol (2 mg/kg) or fentanyl (2 mcg/kg)
three minutes prior to intubation. Vital signs including HR, SBP, DBP, and MAP were recorded
at baseline, immediately following intubation, and at one-, three-, five- and ten-minutes after
intubation. Esmolol was found to prevent a significant increase in heart rate when compared to
fentanyl at one-, three-, and five- minutes after intubation (p<0.001). Additionally, a 6.2%
increase in SBP was observed in esmolol group compared to a 12.9% increase in the fentanyl
group (p<0.01). Varma et al. (2015) conclude that 2 mg/kg of esmolol proves more efficacious
than 2 mcg/kg of fentanyl in attenuating a sympathetic response to intubation.
One mixed methods study and two qualitative studies were discovered that sought to
identify perceived barriers and facilitators for adoption of opioid sparing techniques
perioperatively (Lyon et al., 2014; Schmitt, 2019; Velasco et al., 2019) In the qualitative study
conducted by Lyon et al. (2014), 18 staff nurses working in a hospital employing new Early
Recovery After Surgery (ERAS) protocols were recruited and a series of interviews were
conducted using open-ended questions. ERAS protocols incorporate a multimodal approach to
patient care perioperatively to optimize patient outcomes, including opioid sparing techniques.
The interviews were completed face to face with pre-defined questions to ensure inclusion of
limitations to implementing guidelines. Data was analyzed utilizing a grounded theory approach
and key themes emerged as barriers to implementing new ERAS protocols (Lyon et al., 2014).
Themes included staff-related factors and the difficulty in changing staff behavior and attitudes
(Lyon et al., 2014). Staff responded with difficulty in accepting new ERAS protocols due to their
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current practice as being “handed down” from senior staff and the ideology that “this is how it
was”, as well as confusion with aspects of the new guidelines (Lyon et al., 2014). Researchers
conclude that education of evidence behind practice change would lead to a change in attitude
and behavior (Lyon et al., 2014). This study reflects barriers among registered nurses but may
reflect possible barriers among anesthesia providers, as CRNA education and training is rooted
in nursing practice.
The qualitative study conducted by Velasco et al. (2019) questioned CRNAs about
individual barriers and facilitators to selecting non-narcotic alternatives within the perioperative
setting using a questionnaire format based on components of the previously mentioned
questionnaire developed by Lyon et al. (2014). Information was obtained through open-ended,
verbal questioning conducted via phone interviews. Common barriers to opioid sparing
techniques identified among 112 CRNA’s included belief in opioid superiority, inconsistency of
analgesic effects of opioid alternatives, limited experience with alternatives, limited opioidalternative resources provided, past negative experiences with opioid alternatives, and patient
comorbidities (Velasco et al., 2019). Authors conclude that these findings may guide future
efforts to promote use of opioid sparing techniques.
Lastly, Schmitt (2019) identified that gaps currently exist in educational literature on
opioid free anesthesia designed specifically for anesthesia providers. This mixed methods study
sought to educate CRNAs on opioid sparing techniques within practice, determine if this
education resulted in an increase of non-opioids alternatives administered, and identify barriers
for utilizing these techniques within practice (Schmitt, 2019). A Likert-scale survey was
developed and disseminated to anesthesia providers in a local community hospital to determine
barriers for utilization of opioid sparing techniques in clinical practice, with the goal of
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identifying common themes among responses (Schmitt, 2019). Following education on specific
alternatives to narcotics perioperatively, a chart review was conducted identifying the number of
instances alternatives were used before and after education. Medications identified as alternatives
included ketamine, dexmedetomidine, esmolol, and acetaminophen, to name a few. The medical
records were observed 30 days prior to and 30 days following education, to determine influence
of the educational intervention. This audit demonstrated an increase in the number of nonopioids alternatives administered by CRNAs (p=0.002) following education, when compared to
pre-education results (Schmitt, 2019). Responses of perceived barriers to non-opioid alternative
administration among participants included reluctance of alternatives by surgeons (30.46%),
reluctance of the anesthesiologist (38.46%) and costs associated with alternatives (38.46%)
(Schmitt, 2019). The author concludes that by identifying barriers and providing education,
CRNAs are more apt administer non-opioid alternatives.
Synthesis of Literature
Project designs observed HR, SBP, DBP, MAP, and RPP to evaluate medication success
for mitigating hemodynamic responses at varying time intervals among the six RCTs used within
this literature review. Methods varied regarding dosing of esmolol and fentanyl, as well as time
of medication administration. Despite these differences, all six studies identified statistically
significant findings and evidence reinforcing the use of esmolol as an alternative to fentanyl for
treating the response to intubation (Bostan & Eroglu, 2012; Gupta & Tank, 2011; Prakash et al.,
2019; Ugur et al., 2017; Vaishnav & Chaudhari, 2015; Varma et al., 2015). Among all studies,
no adverse events were recorded at any time interval following esmolol administration,
demonstrating safety of this alternative. These findings provided evidence supporting esmolol as
an appropriate intervention for minimizing hemodynamic responses following intubation.
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Obstacles to implementing opioid sparing techniques are reinforced through findings in
the literature review. Belief in opioid superiority, limited resources on alternatives, limited
experience with alternatives (Velasco et al., 2019), reluctance of peers (Schmitt, 2019), and work
culture (Lyon et al., 2014) are examples of current barriers experienced by anesthesia providers
and staff within the perioperative setting. Understanding these common themes allows
researchers, educators, and managers to prepare interventions to overcome these obstacles, such
as education. The literature review reinforces education as proving effective at minimizing these
barriers and improving adoption of narcotic sparing techniques (Schmitt, 2019).
Rationale
Kotter’s 8-Step Change Model and the Stetler Model of Evidence-Based Practice were
identified as guides for development and implementation of this DNP project. The first theory,
Kotter’s 8-Step Change Model, reflects the notion that individual behavior change occurs more
readily when truths are expressed that illicit feelings, further motivating the individual to adopt
practice change (Kotter & Cohen, 2012). Kotter’s model promotes identification of a problem,
prompts individuals to experience feelings toward that problem and ultimately change behavior.
The eight distinct steps include creating a sense of urgency, formation of a coalition, creating a
vision for change, communicating that vision, empowerment and removal of barriers, short-term
successes, building on change, and nourishing change (Kotter & Cohen, 2012).
Specifically, within this project design, urgency was expressed by educating staff and
stakeholders on alternatives and the current state of the opioid crisis. By creating this sense of
urgency, stakeholders had an opportunity to understand the need for implementation of such a
project to minimize narcotic use, as well as efficacy of non-narcotic alternatives. A team was
developed by identifying stakeholders, including staff within the community hospital of the
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proposed intervention site, and assigned faculty. With those stakeholders, a vision for change
included identifying desired outcomes of education, ways to assess objectives and outcomes, and
development of educational tools.
Communicating this vision to staff took place by disseminating developed education,
addressing barriers along the way. This vision reflected core values of both the organization as
well as individuals and demonstrated how proposed changes in practice will reflect these values.
Anesthesia providers were empowered to use these educational tools by directly removing
barriers associated with implementation and through education on the efficacy of esmolol and
patient outcomes.
Barriers included aspects such as familiarity of esmolol and belief in opioid superiority.
Specific barriers were kept in mind while developing and implementing the educational inservice. Short-term successes included aspects such as developing pre/post-surveys and finding
allotted time for project implementation. By reinforcing findings within practice and increasing
practitioner consideration of esmolol as an alternative, the intent was to nourish and build on this
change. Reinforcement should occur by changing staff perception and continued education
regarding this alternative, if desired. Lastly, this change should be nourished by acceptance of
esmolol use and demonstrated by an observed increase of administration within this setting. By
utilizing this framework, each step of preparation and implementation was identified, providing
the greatest potential for practice change.
As expressed through the PICO question, an in-service was employed rooted in current
evidence from randomized control trials and qualitative findings to promote practice change.
Motivating an individual to adopt practice change often proves difficult. The Stetler Model of
Evidence-Based Practice was utilized to aid in this challenge. Stetler developed specific steps
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that facilitate effective evidence-based practice change through promotion of research findings.
These specific steps include preparation, validation, comparative evaluation/decision making,
translation/application, and evaluation (Stetler, 2001). Preparation of this project included
identification of stakeholders, perceived benefits and threats to implementation, and discovery of
research.
Validation occurs by critiquing research findings and rating various levels of evidence
through a literature search. Comparative evaluation and decision-making involved stakeholders
determining appropriate recommendations for esmolol use based upon evaluated research
findings. Surveys and dissemination of education took place in the translation/application phase,
allowing knowledge of esmolol efficacy to be passed to individuals. Lastly, evaluation included
an audit of esmolol use and post-education survey results. The Stetler Model depicts criticalthinking and decision-making steps aimed to implement safe and effective use of research
findings at an individual and organizational level (Stetler, 2001). This model served in
identifying the applicability of research, highlighting the exact evidence that was used for
education to facilitate change and assisted in implementation and evaluation of education.
Purpose Statement
The purpose of this proposed project was to 1) employ an educational in-service to
anesthesia providers regarding the benefits and recommendations of esmolol use for attenuating
the hemodynamic response to laryngoscopy and endotracheal intubation, 2) improve provider
perception and familiarity with this non-narcotic alternative, and 3) observe an increased rate of
esmolol administration within proposed hospital center.
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Specific Aims
Research validates and recommends the use of esmolol for attenuating hemodynamic
responses following intubation (Vaishnav & Chaudhari 2015). Anesthesia providers are often
rooted in their practice. Perceived barriers and obstacles can exist preventing individuals from
considering newly recommended practice change. The aim of this project was to provide
anesthesia providers with an educational in-service to improve familiarity and perception of
esmolol in preventing hemodynamic responses to laryngoscopy and intubation, while prompting
an increased use within this setting. The content of this in-service focused on identified benefits
of esmolol, recommendations for use (i.e., dosing and contraindications), and methods for
overcoming perceived barriers to administration. By providing education to anesthesia providers,
familiarity, and perception of esmolol did improve, yet there was a lack of application in clinical
practice.
Methods
Context
Anesthesia providers, including both CRNAs and anesthesiologists, employed at local
community hospitals were the population of interest in which the educational in-service was
applied. The hospital of project implementation offers surgical specialties including general,
vascular, urological, gynecological, cardiovascular, and orthopedic services, to name a few (Mon
Health Medical Center, 2020b). With such a vast surgical setting, anesthesia providers are
presented with various treatment considerations. CRNAs and anesthesiologists provide
anesthetic care to a variety of patients and demonstrate both autonomous and collaborative
clinical decision making. This program provided anesthesia providers with heightened
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familiarity of esmolol as a safe and efficacious alternative, as well as highlighting important
aspects of utilizing non-narcotic alternatives in practice.
Intervention
This quality improvement project was developed and implemented alongside
stakeholders, including the designated faculty of record (FOR), chief anesthesiologist and chief
CRNA at a local community-based hospital. Project development began by collaborating with
stakeholders to develop intended content for the educational in-service and pre/post-education
surveys to determine familiarity, perception, and barriers of esmolol administration. Educational
content was derived from previously evaluated literature and stakeholder input. Stakeholders
were given an opportunity to provide additional resources to support and be included in
educational content.
Success of the educational intervention was evaluated by comparing pre/post-survey
responses. Surveys were developed utilizing the Qualtrics Data Software offered through West
Virginia University. The pre-education survey was provided to all anesthesia providers
(including both physicians and CRNAs) prior to initiation of the in-service, to identify current
esmolol use, degree of familiarity and perception of esmolol use prior to intubation. Utilizing a
Likert Scale, surveys inquired about satisfaction with opioid alternatives, desire to change
practice, and if reluctancy to practice change exists. Two multiple choice questions offered in the
survey were used to assess knowledge of esmolol administration, specifically dosing and
administration outcomes. Lastly, the survey ended with an open text opportunity for participants
to respond with any additional remarks, concerns, or barriers with esmolol administration.
Pre-education surveys were provided for completion on the day of project
implementation prior to beginning the in-service. Surveys were completed void of any
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identifying information for the individual completing the survey. This pre-education survey
intended to take no more than two minutes for completion (Appendix E). Following the preeducation survey period, the educational in-service was conducted. Specified days for education
were identified within the site of implementation with the assistance of key stakeholders that
manage anesthesia staff. The site of implementation offers conference rooms in which the inservice took place. This education was developed and portrayed as a PowerPoint presentation.
To maintain the anonymity of anesthesia providers in attendance, a simple numerical count to the
number of anesthesia providers who attend each session was conducted for record keeping. An
accurate numerical record of those who participate in this in-service proved necessary for future
data analysis of findings from pre/post-surveys.
Educational content found within the in-service included characteristics of esmolol
alternatives (mechanism of action, dosing/timing recommendations, appropriate patient
considerations and exclusion criteria), associated clinical benefits of esmolol, perceived barriers
to esmolol use, methods for overcoming these barriers, cost comparison to fentanyl and
medication availability. The number of days in which the educational in-service was offered was
subject to change and dependent upon the number of anesthesia providers present for each
meeting, number of available days for education implementation, and any restrictions due to the
current COVID pandemic.
Following the in-service, time was provided for questions or comments as well as
completion of the post-education survey. Fincham (2008) recommends a survey response rate of
60% for appropriate data analysis and this benchmark will be the goal for this project. To
facilitate this response rate, post-education surveys were provided immediately following the inservice. The post-education survey mirrored the pre-education survey. This post-education
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survey made available via e-mail if restrictions applied. By comparing pre-education and posteducation responses, researchers sought to identify if educational interventions improved
provider perception and familiarity with esmolol use.
Both pre/post-education surveys were completed in-person, either through paper hard
copy or through a link accessible through participants personal cellular device. As most carry
their personal cell phone on their person, these devices were used to access the survey via a QR
code offered through the Qualtrics Software system. The QR code was presented on the first
slide of the educational in-service. Participants could use their camera to capture the QR code
within the frame. Once captured, a link auto-populated on the individual’s screen. By clicking
this link, they were directed immediately to the pre-education survey. This same process was
available following the last slide of the educational in-service to access the post-education
survey. Responses to both pre/post-education surveys were compiled through Qualtrics software
for statistical analysis and completed at a latter phase of project analysis through SPSS software.
An audit was conducted to observe if education influences the rate of esmolol
administration within this setting. This audit, performed alongside hospital staff, was collected to
quantify esmolol use during laryngoscopy and intubation for a three-month period prior to
education and post-education. This audit aimed to identify the number of specific instances in
which esmolol was used prior to laryngoscopy and endotracheal intubation. Audit information
did not include specific patient information or identifiers, but rather a number reflecting esmolol
administration within this setting. The audit itself was conducted alongside the chief CRNA at
the site of implementation. This retrospective chart audit utilized Mon Health Medical Center
Electronic Health Record (EHR) system, Cerner. The primary researcher developed an audit tool
for appropriate identification of applicable medication administrations (Appendix G). Medical
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information accessed from patient EHR’s existed prior to audit implementation, and recorded
data was void of any protected health information (PHI) ensuring anonymity of patients and
confidentiality of medical records. To ensure confidentiality of patient charts during data
collection, charts being audited received a de-identifying number for record keeping. Deidentifying numbers were assigned to each chart simply to reflect the number of charts being
reviewed on the day of audit (i.e., chart number one, two, three etc.). Access to medical records
was granted by Mon Health Medical Center IRB and Privacy Officer. A formal HIPAA waiver
did not exist, but proof of personal communication granting access is attached in Appendix H.
Success of education was concluded by a comparative analysis of pre/post-education survey
results and retrospective chart analysis of esmolol use within designated time frames.
Data from the pre/post-surveys and the numerical value of esmolol use discovered
through the retrospective chart review was collected and stored in electronic form on a locked
computer of the primary investigator. Specifically, pre/post-surveys were collected and stored
via Qualtrics software in a personal locked account of the primary investigator, only accessible
through individual username and password. Only the primary researcher could access the
information from pre/post-surveys. If hard copies of the surveys were required, a lock box was
available for participants to confidentially place these once completed. These paper surveys
could have been transcribed to the electronic Qualtrics software by the primary researcher,
alongside the Faculty of Record to ensure accuracy. Once completed hard copies were translated
to electronic form, these hard copies would have been shredded and discarded. Information
gathered via the esmolol audit was secured on the same locked electronic device. This portable
electronic device could only be accessed by the primary researcher and required a specific
password for entry. Following the data analysis of discovered data, results from the pre/post-
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surveys were deleted from the Qualtrics account to ensure destruction. Electronic reporting of
esmolol use through the developed audit tool was also deleted from the locked electronic device.
Gaps and Benchmarks
Certain gaps in knowledge exist and have been identified. Through extensive literature
searches, there has yet to be a uniformly recommended educational method for influencing
esmolol use. Additionally, there has yet to be a discoverable survey previously implemented for
identifying individual’s perception and familiarity with esmolol. With this in mind, resources
were sought to assist in successful project development. The World Health Organization (2005)
has developed a manual specific to educating healthcare providers titled Effective Teaching: A
Guide for Educating Healthcare Providers, with recommendations to build knowledge, improve
clinical skills, and increase adherence to recommendations. Similarly, The Health Foundation
(2012) published Quality Improvement Training for Healthcare Professionals assisted with inservice development. Utilizing these resources to improve upon methods to educate healthcare
providers, there was an anticipated increased likelihood of adherence to recommendations and
effective practice change.
Benchmarks to compare success of project implementation have not been discovered on a
national level. The American Society of Anesthesiologists (ASA) has supported the reduction of
patient exposure to opioids perioperatively. Recently, the ASA has urged legislative initiatives
aimed at minimizing opioid use and improved data collection of best practice. In 2018 Congress
passed the S. 2680, Opioid Crisis Response Act bill, which was developed to facilitate opioid
sparing techniques and provides grants to hospitals that utilize alternatives to opioids when
available (ASA, 2018). Additionally, the H.R. 5178 Perioperative Reduction of Opioids (PRO)
Act was passed in which the U.S. Department of Health and Human Services Technical Expert
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Panel have been employed to reduce perioperative opioid administration and collect data on
opioid administration in these settings (ASA, 2018). These legislative acts align national goals
with those included within this project, including minimization of opioid administration and
effect practice change when alternatives to narcotics exist.
Feasibility Analysis
In order to facilitate appropriate project implementation, a needs assessment was
completed. This assessment determines necessity and feasibility of the project. Strengths,
weaknesses, objectives, and threats (SWOT) analysis was also conducted to provide guidance
with project development specific to the proposed site of implementation.
Needs Assessment
Fentanyl administration remains a customary treatment option during laryngoscopy and
endotracheal intubation. Despite adverse outcomes associated with fentanyl use perioperatively
including nausea, vomiting, hypercapnia, and postoperative respiratory complications, it is still
considered preferable among many anesthesia providers (Friedrich et. al, 2019). Within hospital
facilities, including the site of project implementation, providers do not exhibit uniformity
among practice techniques. Some anesthesia providers use opioid sparing techniques more
frequently than others, based upon various aspects of consideration (Dr. M. Coleman, personal
communication, July 3, 2020). By developing an educational tool available to all anesthesia
providers, unanimity among best practice is promoted. Developing common practice techniques
can assist in minimizing barriers for non-narcotic alternative use, reinforce knowledge and
improve patient outcomes.
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Feasibility
Feasibility was assessed to determine barriers and practicality of the proposed project.
Project design involved constructing pre/post-surveys and an educational in-service alongside
stakeholders. Development of education and pre/post-surveys was done electronically,
minimizing disruption in the schedule of stakeholders. The pre/post-surveys included questions
unique to this project. In-service content came from published research articles and
recommendations from stakeholders. Pharmacy staff assisted in ensuring that content reflected
standard esmolol dosing available within the anesthesia cart, as esmolol was found in most
anesthesia carts within hospital facilities. This promoted ease of accessibility and administration
while preventing pharmacy from having to stock this medication upon request.
A cost comparison between fentanyl and esmolol was identified to determine financial
feasibility within the specific hospital of implementation. A standard vial of injectable fentanyl
(100 mcg/2cc) has an associated cost of $0.63 while the standard vial of injectable esmolol (100
mg/10cc) has an associated cost of $2.17 per vial (Ms. Kathy Miller, personal communication,
September 3, 2020). Dosage recommendations for fentanyl (1-2 mcg/kg) and esmolol (1-2
mg/kg) are comparable regarding cost per microgram and milligram of medication. These costs
demonstrate a comparative financial impact and reflect financial feasibility when using esmolol
as an alternative.
Methods and opportunities for education affected overall feasibility of this quality
improvement project. In-service education is most effective if conducted in a group setting.
Routine meetings for anesthesia providers are conducted within the chosen site of
implementation and proved to be an opportune time for education to take place.
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Outcomes identified that would classify this project as successful included increased
esmolol administration and improved provider familiarity and perception with this non-narcotic
alternative. Measuring these outcomes occurred by the previously mentioned audit and survey
compilation and comparison. Proposed risks of this project included compromised participant
confidentiality, incorrect use of esmolol, and lack of consideration for change following
education. The in-service included appropriate patient considerations for use, indications,
contraindications, and recommended dosing to mitigate medication risks. Prior to beginning the
in-service, participants wishing to participate within this in-service were offered an informative
cover letter, defining methods used to ensure participant confidentiality. This cover letter
informed participants that inclusion within this research design was completely voluntary,
alongside potential risks, benefits, timeframe of research, withdrawal process and researcher
contact information. Participants obtained a copy of this cover letter. Additional aspects of this
cover letter may be found in Appendix F.
Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis
A SWOT analysis was completed to assist in project planning. Strengths associated with
this quality improvement project included ease of implementation, minimal cost associated, and
observation of both quantitative and qualitative outcomes for program analysis. Weaknesses
within project design included the need for dissemination of education to multiple providers and
potential pushback for practice change. Attempting to educate the entirety of the anesthesia
department proved difficult due to schedule conflicts, constant workflow throughout the day and
interruptions during education. The anesthesia staff within the hospital could have consisted of
senior staff members with rooted clinical experience who were unwilling to change their
individual practice.
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Opportunities that were available within this project included evidence-based practice
change, reinforcement of an efficacious alternative, minimization of narcotic use, improved
clinical outcomes, and acceptance for both individual and organizational change. Threats for
implementation included the current COVID-19 pandemic minimizing in-person educational
opportunities, cost comparison between esmolol and fentanyl specific to the implementation site,
and lack of desire to change practice. These threats were identified and considered throughout
the entirety of project development, implementation, and analysis.
Budget
The budget associated with this project design was minimal due to selected methods.
Education and pre/post-education surveys were developed using freely accessible information
through online resources offered through West Virginia University including EbscoHost,
PubMed and Qualtrics software. Much of this project was electronic and required limited
physical materials to be purchased. A cost was associated with the pre/post-education surveys, as
they were printed in paper form for completion if desired. Additionally, a breakfast was provided
for those who attend allotted days of in-service. This was not a mandatory expense but offered a
greater chance for employee attendance and to express gratitude to staff for the opportunity to
implement this project. Specific aspects and breakdown of the budget may be accessed in
Appendix B.
Sustainability
This project was performed as a quality improvement project. Sustainability is dependent
upon anesthesia providers adopting evidence-based practice change, utilization of change
clinically, and future dissemination of education to peers and newly hired staff. If anesthesia
providers adopt practice change and pass knowledge along, this quality improvement project will
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prove sustainable. If successful as intended, protocols may be developed within the site of
implementation.
Technology
Most of the technology within this project design was required by the researcher and
stakeholders related to developing education and surveys. This technology included PowerPoint
and Qualtrics computer software. Education occurred via PowerPoint offered in a group setting
via projector, all of which were available at the site of implementation. Anesthesia staff were not
responsible for utilizing newly identified technology for project implementation.
Technical Equipment
Medications for administration can be considered aspects of equipment within project
design. Both esmolol and fentanyl were readily available within anesthesia carts located in
operating rooms. No additional equipment or mixing of medications was required by the
anesthesia provider when deciding to administer either fentanyl or esmolol.
Key Personnel
Stakeholders are considered key personnel. This included the assigned faculty of record
(FOR), chief anesthesiologist, chief CRNA, WVU statistician, pharmacy staff and all staff
anesthesia providers within the identified site of implementation. These key personnel assisted
with aspects of project design including developing appropriate education and pre/post-surveys.
Pharmacy staff assisted in finalizing educational content and determining costs associated with
esmolol and fentanyl administration, demonstrating feasibility and sustainability with esmolol as
an alternative. A statistician employed at WVU assisted in statistical analysis to evaluate
program findings and success. Lastly, anesthesia staff were vital for this project. Education was
geared toward the anesthesia provider and required their inclusion for specific objectives and
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outcomes to occur. All personnel were necessary for successful implementation of the desired
project and outcomes were dependent upon collaboration of all identified.
Congruence with the Organization’s Strategic Plan
The mission plan of the desired implementation site included specific values and visions.
Examples included respect, excellence, and teamwork (Mon Health Medical Center, 2020a). The
mission plan reads as:
“…to enhance the health of the communities we serve, one person at a
time (Mon Health Medical Center, 2020a).”
Additionally, hospitals may have a proposed strategic plan, including:
“To prepare for the future, we must respond with a strong commitment to
our mission, vision, and values. Recently, the Board of Directors adopted revised
mission, vision and values statements that better reflect our current culture,
healthcare environment and community needs. Though the language has changed
slightly, our commitment to high-quality and safe care remains our top priority, as
does delivering an exceptional patient experience.

Mon Health will focus on providing the best, most effective and affordable care to
our patients, and will ultimately enhance the health of the communities we serve.
Additionally, as the system grows, it becomes more critical that all entities are
aligned. The elements of our new strategic plan will provide the framework for
this focused work (Mon Health Medical Center, 2020a).”
The underlying goal of this project was to increase evidence-based practice within the
perioperative setting, allowing for optimal treatment and outcomes of patients. Adhering to
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current evidence-based practice to minimize adverse outcomes associated with narcotics, the
health of the community may be enhanced by utilization of esmolol in practice. Clinical
excellence should be further demonstrated by facilitating provider awareness and familiarity with
efficacious interventions.
Evidence of Key Site Support
The primary stakeholders identified with this project were the chief anesthesiologist and
chief CRNA at an identified site of implementation. Both individuals expressed support of this
project design. Attached documentation of such support is available (See Appendix C).
Stakeholders assisted throughout the entirety of this quality improvement project and expressed a
desire in improving staff knowledge of non-narcotic alternatives within the perioperative setting.
This project design was congruent with that desire. Additionally, interim, and final reports were
provided to the Mon Health IRB Chair throughout implementation and upon completion of
research.
Project Timeline
The anticipated start date for this project was the fall of 2020. Throughout October of
2020, the primary researcher collaborated with key stakeholders to develop the educational inservice and pre/post-surveys. During this same month, IRB approval was sought. Following IRB
approval, the educational in-service was finalized alongside stakeholder input. Desired dates of
project implementation and data collection were in December and January 2021. Dates of
implementation were contingent upon availability of conference rooms, staff scheduling, and any
restrictions based upon the current COVID-19 pandemic. Due to these restrictions, the single
date of project implementation was March 31, 2021. Staff completed the pre-education survey,
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attended the educational in-service, and completed post-education surveys within the same day.
Results of these surveys were compiled following the educational in-service.
Dates specified for the audit comparing esmolol use pre- and post- education were
dependent upon completion education. The desired timeframe for audit inclusion was three
months prior to education compared to the initial three months following education. Proposed
months for audit included comparing esmolol use in December 2020, January, and February
2021 to that of April, May, and June 2021. For timeframe purposes, data analysis of the surveys
and audit were scheduled to take place in August and September of 2021. A thorough and
updated timeline for this project design was developed using the SMART Workplan with
detailed dates presented (Appendix A).
Study of the Intervention
An approach was chosen for not only assessing the impact of the intervention, but also to
ensure that the outcomes were accomplished due to specific interventions. The Logic Model was
employed to meet this goal, as this model establishes the relationship between the program’s
activities and specific outcomes (CDC, 2018b). This model incorporates aspects such as inputs,
activities, outputs, outcomes, and impacts to determine impact of interventions (CDC, 2018b).
Inputs for this specific project design included the previously mentioned key stakeholders,
resources for educational development, technology, and associated materials. Activities included
the educational in-service about esmolol use and efficacy, and pre-education surveys.
The outputs within this project included the completion and compilation of posteducation survey results, and an audit of the amount of esmolol administered prior to intubation
pre/pos-educational in-service. Outcomes were categorized as short-term, intermediate, and longterm outcomes (CDC, 2018b). Within this project design, short-term outcomes included
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improved provider familiarity and perception of esmolol during the educational in-service and
immediately following. Intermediate outcomes included continued improved perception and
familiarity, minimization of barriers to use, collaboration of this practice with peers and an
agreeance of clinical applicability. Long-term outcomes include an observed increase in the
number of instances esmolol was administered prior to intubation, improved staff perception and
familiarity of esmolol use, and the development of new protocols for practice. The Logic Model
assisted in determining the impact of specific interventions in relation to observed outcomes
within this project design.
Evaluation Plan
The evaluation plan was developed for determination of specific objectives and outcomes
proposed within this quality improvement project. This plan contained the aims, outcome, target
population, data collection, methods for collection, and data analysis relevant to each objective
proposed within the project design. The evaluation plan reinforced individual outcomes and
objectives within the implementation phase and addressed methods for interpretation of results
(Appendix D). Both quantitative and qualitative data gathered from collection methods was used
to determine final data analysis within this project design.
The first outcome set to occur was an increase of esmolol use within this specific clinical
setting. Success of this outcome was to be demonstrated by anesthesia providers electing to
administer esmolol, rather than narcotic options, prior to laryngoscopy and endotracheal
intubation. The target population included all anesthesia providers within a community medical
center. Data for collection was quantitative to determine the specific number of instances that
esmolol was utilized prior to laryngoscopy and intubation. The collection of this data occurred in
collaboration with stakeholders, allowing anonymity between patient and observer.
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This audit compared esmolol use three months prior to the educational in-service to use
three months following the in-service. Only esmolol administered for attenuation of
hemodynamics to intubation was considered for analysis. Esmolol given under additional clinical
circumstances (i.e., prior to sternotomy, treating tachycardia) was not applicable for analysis.
Reliability and validity were a concern while completing retrospective chart audits. Inconsistent,
incomplete, and lack of appropriate documentation threaten reliability of audit results and was
considered when analyzing data (Wickson-Griffiths et al., 2014).
The second outcome of intended measure was to improve provider perception and
familiarity with esmolol administration. Objectives determined to measure this outcome included
utilizing a developed survey presented to anesthesia providers for completion pre/post-education.
After reviewing subsequent literature searches, a tool for measuring improved provider
perception has not been developed and one had to be constructed. Likert-scale responses were
used for development of this survey, alongside two multiple-choice questions, and an open-text
response question. All responses to the Likert-scale statements had a weight associated, and this
weight was used for quantitative analysis. The multiple-choice questions were analyzed to reflect
knowledge of esmolol. The last question within this survey was open text in which staff could
express individual concerns, remarks, or additional barriers with esmolol use.
Survey collection was completed in-person through an electronically accessible survey,
or hard-copy paper form if preferred. Qualtrics data software, offered through West Virginia
University, was used to gather and compile results of both pre- and post- education surveys.
Results from the survey remained anonymous. The same survey questions used for pre-education
analysis were recirculated for completion following the educational in-service for post-education
comparison. Validity and reliability of developed survey tools was not established and was
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considered when analyzing statistical findings. One tool that assisted in establishing reliability of
developed surveys and Likert-scales results was the Cronbach’s alpha test. This test measures
internal consistency of a developed instrument and can speak to the level of reliability when
discussing findings (Heale & Twycross, 2015).
Measures
Measurable Objectives
Utilizing the SMART plan, specific objectives were employed to monitor progress. This
plan ensured that objectives were specific, measurable, achievable, realistic, and time phased
(CDC, 2018a). The objectives of this project design included overcoming barriers to nonnarcotic administration, familiarization with the esmolol within a specific clinical setting, and
prompting esmolol administration prior to laryngoscopy and endotracheal intubation. These
objectives had to be measurable, assessed through the specified audit and comparison of Likertscale survey results. The reference point to compare a measurable change included the instances
of esmolol use prior to education and pre-education survey results. Developed Likert-scale
questions had five response options with associated number value for data analysis (strongly
disagree- 1, disagree- 2, neither agree or disagree-3, agree-4 and strongly agree-5). Two
knowledge-based questions aimed to observe knowledge through correct/incorrect responses to
questions. Utilizing the Qualtrics software, completed surveys were accessed by the participant
and results were accurately and timely compiled.
These objectives were achievable, realistic, and time-bound based upon the developed
project design and SMART workplan. Determining success of implementation included an
increased rate of esmolol use, improved familiarity, and minimization of perceived barriers. The
specific SMART workplan developed for this project may be referenced in Appendix A and
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were designed to ensure completion of appropriate checkpoints and documentation throughout
project design and implementation. By following this SMART plan design, alongside Kotter’s 8Step Model and the Stetler Model of Evidence-Based Practice, individual aspects of project
design and implementation were considered in a stepwise approach, ultimately increasing the
likelihood of program success.
Analysis
Both quantitative and qualitative data were analyzed with assistance of Statistical Product
and Service Solutions (SPSS) software. Analysis of pre/post-education survey results were
achieved by descriptive statistics alongside the nonparametric Wilcoxon signed-rank test. The
Wilcoxon signed-rank test is appropriate for data analysis of Likert-scale results since surveys
identify and compare changes in responses among the same participants after an applied
intervention (Laerd Statistics, 2018). For example, the Likert scale survey can have the following
response options regarding level of agreeance with a statement: Strongly Disagree, Disagree,
Neither Agree or Disagree, Agree, and Strongly Agree. Each response had an associated weight,
being one through five, to provide ordinal data per response. These numbers were used to score
the Likert scale and allow analysis of responses between the pre/post- surveys. Cronbach’s Alpha
scores were calculated to establish reliability of the developed surveys and Likert-scales results.
The qualitative findings from the last survey question were analyzed using a grounded theory
approach, set to capture categories among responses, identify a relationship between them and
present the qualitative findings (Lyon, 2014). Lastly, a paired t-test was employed to analyze
results from the two multiple choice question results and audit comparing esmolol administration
rates pre/post-education when the outcomes is normally distributed. Throughout data analysis, pvalues equal to or less than 0.05 were considered statistically significant. A statistician employed
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through WVU assisted in statistical analysis of data to ensure appropriateness of methods and
outcomes.
Ethical Considerations
The entirety of this project was developed with ethical standards taken into consideration.
A proposal was submitted to the IRB for approval of not only project design, but ethical
standards as well. An ethical consideration when implementing this project was to ensure staff
anesthesia providers were entirely aware of their role within the study. Transparency was
maintained when completing education and implementing study interventions. Staff were made
aware that their decision on medication administration following education would not be
scrutinized, as this notion could have ultimately impacted outcomes. Staff received information
in an unbiased environment, so they could understand that education was presented in an
informative basis only and not from preferential standpoint. Lastly, while conducting the audit to
determine esmolol use pre/post-education, ethical considerations of confidentiality were
considered. To address this issue, the audit was void of patient identifiers or clinical outcomes.
The audit simply represented the total number of cases in which esmolol was administered prior
to laryngoscopy and endotracheal intubation.
Results
Intervention Steps and Evolution Over Time
The developed educational in-service was offered during a scheduled staff meeting
encompassing both CRNAs and anesthesiologists. Two weeks prior to the implementation date,
an email was delivered to all anesthesia staff notifying them of the meeting, allowing the inservice to be provided to the entirety of the anesthesia department if they chose to attend. The inservice began with the pre-education survey. Following completion of this survey, an educational
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PowerPoint was provided demonstrating evidence-based research regarding esmolol as an
efficacious alternative to fentanyl during laryngoscopy. Following completion of the PowerPoint,
time was allotted for questions and discussion from participants. A post-education survey was
then completed utilizing the same questions offered in the pre-education survey. Data was
analyzed for the pre- and post- education surveys from all participants. An audit was conducted
observing esmolol use three months prior to and following the in-service to determine whether
the in-service prompted an increased use of esmolol within this clinical setting. Proposed dates
for interventions were altered throughout the IRB approval and implementation phase of this
project due to the COVID-19 pandemic and pending IRB approval with corrected and accurate
project timelines presented in Appendix I.

Measures and Outcomes
Measurements utilized within this project design include results from the pre- and posteducation surveys including Likert-scale responses, multiple choice knowledge-based questions,
an open-ended text response question and the audit identifying the number of instances esmolol
was utilized during the induction phase of the anesthetic within general surgical cases during
specified time frames. A total of 16 anesthesia providers attended the in-service and completed
surveys. The audit was completed in a retrospective manner by identifying the total number of
surgical cases requiring endotracheal intubation, the number of these cases in which esmolol was
administered, and identification of the clinical requirement of esmolol administration. The
occurrences were discovered utilizing the developed audit tool found in Appendix G.
The implemented surveys aimed to evaluate anesthesia staff knowledge and familiarity of
esmolol administration, perceived barriers to esmolol use, and reluctancy in utilizing esmolol
within this clinical setting utilizing seven Likert-scale based responses. Surveys also consisted of
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two multiple choice questions serving as knowledge-based evaluations determining staff
knowledge of esmolol dose and clinical efficacy. The last question offered an open text response
in which staff could voice individual concerns or remarks to utilizing esmolol.
Based upon responses of anesthesia staff, four of the seven Likert-scale surveys yielded
statistically significant results, defined as a p value <0.05 following data analysis, of responses to
each question when comparing pre- and post-education surveys. A statistically significant
improvement in the following responses was discovered: “I am familiar with the use of esmolol
for attenuating the hemodynamic response to laryngoscopy and intubation” (pre-3.37, post- 4.38,
p=0.009), “I consider esmolol an appropriate alternative to fentanyl for use to attenuate the
hemodynamic response to laryngoscopy and intubation” (pre- 3.69, post- 4.44, p=0.008),
“Fentanyl provides greater efficacy than esmolol in attenuating the hemodynamic response to
laryngoscopy and intubation” (pre- 3.33, post- 2.19, p= 0.004), and “Additional resources are
needed within my institution regarding the use of esmolol for attenuation of the hemodynamic
response to laryngoscopy and intubation” (pre- 3.88, post- 2.81, p= 0.009). Other results from
the three additional Likert-scale questions displayed improved scores but were not considered
statistically significant regarding mean values.
Two knowledge-based questions yielded statistically significant outcomes when
observing pre- and post-education results. For the question “The recommended dosing for
esmolol prior to laryngoscopy and endotracheal intubation is:”, 10 of 16 responses were correct
during the initial survey. These same respondents improved to all 16 being correct in posteducation surveys (p= 0.009). For the question, “Esmolol is proven effective in preventing what
hemodynamic considerations following intubation:”, 10 of 16 responses were correct, with 14 of
16 correct responses in the post-education phase (p=0.041).
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The surveys concluded with an open text format response in which the participants were
given an opportunity to provide any comments or concerns regarding barriers or the general use
of esmolol to attenuate the hemodynamic response to laryngoscopy and endotracheal intubation.
Various themes emerged, including anesthesia provider hesitancy to change individual practice
away from fentanyl use, further education being warranted to implement true change, concerns
for adverse outcomes with esmolol use such as bradycardia, and the belief that overall work
culture still supports fentanyl use.
Lastly, the initial audit of esmolol administration yielded 44 instances in which esmolol
was administered within specified clinical timeframes, with zero of these instances being
administered prior to laryngoscopy and intubation. Three months following the in-service, the
audit yielded 45 instances of esmolol administration, with only one administration being prior to
laryngoscopy and intubation. These findings were not statistically significant when comparing
results (p= 0.16). Findings from Likert-scale, knowledge-based survey questions and free text
responses may be found in Appendix J, while results from retrospective esmolol audits may be
found in Appendix K.
Unintended Consequences and Missing Data
Throughout this project’s tenure, certain unanticipated obstacles arose throughout the
intervention stage of project implementation. The initial proposal elected for the entire anesthesia
department to meet for the in-service during monthly anesthesia department meetings. Due to the
COVID-19 pandemic, these meetings were temporarily put on hold. The date of the educational
in-service implementation was one of the first departmental gatherings since the pandemic, and
several of the staff did not attend. This could be attributed to several causes including disinterest,
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preference to avoid meeting in larger gatherings, and the elective nature of the in-service. No
unexpected costs were observed throughout this project.
Discussion
Summary
Key findings from this project reflected aspects of the aforementioned problem statement,
including specific aims and rationale of project implementation. The problem statement
recognized that barriers to narcotic sparing techniques exist among providers yet improving
familiarity and perception of esmolol as an efficacious alternative may increase its use in this
clinical setting. The aim of this project was to improve familiarity and perception of esmolol in
preventing hemodynamic responses to laryngoscopy and intubation, while prompting an increase
in rates of administration. Aims were partially met following analysis and interpretation of preand post-education survey results and esmolol administration audits. The educational in-service
proved effective in educating staff of all experience levels. Familiarity, knowledge, and
perception of esmolol improved among anesthesia providers but did not prompt a practice
change.
Various strengths of this project were identified. Opioid sparing techniques are beginning
to be implemented across the nation. This project offered insight into one such technique and
improved anesthesia provider knowledge on this topic if a future practice change is warranted.
This alternative treatment is not an exhaustive change in practice for the anesthesia provider,
making it more attainable. This education reinforced interprofessional collaboration by offering a
talking point between CRNA’s and anesthesiologist regarding anesthesia techniques. The
conversations that followed the in-service offered opportunities to discuss practice techniques
and discussion about alternative anesthetic techniques. Within the project design itself, Qualtrics
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data software made survey completion easy for the participant and data compilation
straightforward. There was no monetary requirement for participant or project designer.
Interpretation
Anesthesia practice is rooted in core fundamentals but continues to advance daily,
offering individual practitioners’ opportunities for continued learning and adaptation within their
practice. Practice change may be warranted for various reasons, including desire to improve
patient outcomes or the impact of national trends, such as the current opioid epidemic.
Healthcare professionals may be educated on these alternative treatments and apply them to their
practice. The findings of this study reflected this notion. Anesthesia providers who attended the
educational in-service did not object to education regarding esmolol as an alternative to fentanyl.
They were pleased to discuss this alternative and demonstrated increased knowledge compared
to baseline familiarity. The intervention to improve knowledge and understanding was
successful. Yet, there is a lack of translation into practice. This could be on behalf of the
individual or culture. Anesthesiologist and CRNA’s develop their practice over time and through
experience. They appreciate familiarity with their practice of choice and have shaped their
anesthetic approach based upon successful outcomes. One educational service regarding
alternatives may not be enough to motivate practitioners to adopt change. This notion was
reinforced in the audit results yielding no significant increase in esmolol administration. Through
interventions, barriers were identified that reflect these findings including the need for additional
education, need for cultural change and buy-in from the entirety of the anesthetic team. Similar
findings were demonstrated in the study conducted by Schmitt (2019), in which CRNA’s
expressed barriers to various opioid sparing techniques, including lack of acceptance throughout
the department and increased costs associated with such alternatives. Interestingly, the study
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conducted by Schmitt (2019) demonstrated that an educational in-service on various nonnarcotic alternatives, including esmolol, yielded an increased use of alternatives in practice. This
adoption of alternatives into practice may be due to education involving several non-narcotic
options, rather than one specific alternative.
This QI project directly impacted both the individual practitioner and healthcare system.
Despite being teachable and accepting of improved knowledge, anesthesia providers will require
continued education if institutions wish to make a cultural change. This would mean further time
and costs with training and educational tactics. Additionally, if facilities wish to implement
opioid sparing techniques, the barriers and concerns expressed by these providers must be
addressed and education should be developed with barriers in mind. Further education and
training can utilize the findings from this study to increase the likelihood of implementing
change within their institution.
Limitations
Limitations were identified throughout project implementation and analysis. The entirety
of the anesthesia department was unable to attend the in-service, with the sample size being
relatively small (n=16). The sample size may limit generalizability of results and cause concern
for potential bias. This bias may limit the internal validity of findings. Since all 16 participants
completed pre- and post-education surveys, certain biases were addressed, such as non-response
bias. As participants were fully aware that the research was conducted by a student, acquiescence
bias was addressed by utilizing Likert-scale responses, rather than yes/no response options.
Lastly, to reinforce validity, participants were informed that their responses were completely
blind, aiming to illicit the truest responses from participants.
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To fully address limitations to generalizability, future education and studies should be
implemented to the entirety of the department. The site of project implementation was a
community hospital setting. Different outcomes may have been identified if interventions were
conducted at a teaching facility, where such concepts as the new ERAS protocols and opioid
sparing techniques may be more commonplace. A multi-facility approach to further research
may improve internal validity of study results. Additionally, experience could have played a role
in survey responses. CRNA’s and anesthesiologist with less experience may be more inclined to
change practice compared to senior staff with more experience and confidence with their
techniques.
Conclusion
An educational in-service regarding esmolol as an alternative to fentanyl administration
offered to anesthesia providers allows an opportunity for improved knowledge and
understanding of one type of opioid sparing technique. This education not only improved staff
knowledge but identified barriers to implementation that can be addressed within the department.
Based upon findings within this project, further education regarding such alternatives is
recommended. Additionally, interprofessional communication regarding anesthetic plans and
techniques between CRNA’s and anesthesiologists is needed to further advance individual and
institutional anesthesia practice.
Sustainability of the project is dependent on the adoption of opioid sparing techniques
within individual CRNA and anesthesiologist practice. Anesthesia providers have the
responsibility to provide safe and efficacious care to patients they treat. If providers are
uncomfortable with such alternatives, they should not be utilized until further appreciation of
such techniques is met. With the development of the worsening opioid crisis within the United
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States, ERAS protocols and narcotic-sparing approaches are becoming vital care options,
proving the need for anesthesia providers to be familiar with such techniques. Patients may
present to the operating room with specific requests, including limiting narcotic use. Institutions
may develop protocols outlining anesthetic plans for such requests, in which esmolol may be
applied. Further education is recommended. This education could be provided in the form of
flyers, email reminders, annual training, or continuing education within the facility. By
reinforcing the learning provided in this in-service, the potential to overcome barriers would
increase. Increased esmolol use and acceptance of these evidence-based practice
recommendations may ultimately lead to enhanced patient outcomes and improved health of
communities.
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Table 1
Evidence Table
Author(s),
Title, Year
Bostan, H.
and Eroglu,
A. (2012)
Comparison
of the
Clinical
Efficacies of
Fentanyl,
Esmolol, and
Lidocaine in
Preventing
the
Hemodynami
c Responses
to
Endotracheal
Intubation
and
Extubation.

Aims/Purpo
se

Sample Description

Design / Method

Compare the
efficacy of
intravenous
fentanyl,
esmolol and
lidocaine on
preventing
significant
hemodynami
c response to
intubation
and
extubation.

-120 patients
-Ages 18-65
-ASA class I or II
-Mallampati grade I
-Karadeniz Technical
University Medical
Facility
-Any operation other
than cardiac under
general anesthesia
requiring ETT.
-R/O criteria: morbid
obesity,
cardiac/respirator
disease, allergy to
study drugs,
prescribed
antihypertensive
medications, opioid
use, history of
difficult intubation.

RCT
Three groups:
Fentanyl: 1 mcg/kg
Esmolol: 1 mg/kg
Lidocaine: 1 mg/kg
Control: 10 ml
NaCl
Thirty participants
per group. Study
was double blind,
with numbering for
randomization.
Only the author
knew the drugs
being administered.
Induction followed
by thiopental and
vecuronium.
SBP, DBP and HR
recorded before
induction, at
laryngoscopy and
after intubation at 1,
3, 5, and 10
minutes.

Major
Variables/Measureme
nts/ Analysis
IDV1: Fentanyl 1
mcg/kg
IDV2: Esmolol 1
mg/kg
IDV3: Lidocaine 1
mg/kg
IDV4: NaCl 10 cc
DV1: SBP
DV2: DBP
DV3: HR
Kolmogorov-Smirnov
test used to determine
normal distribution.
ANOVA and Dunnett
test for comparison.
Chi square test for data
analysis.

Results

Conclusion
Strength/Weakne
sses

Esmolol,
lidocaine and
fentanyl all
work to prevent
significant
response in HR,
and BP
compared to
control group.

Conclusion:
Esmolol, fentanyl,
and lidocaine are
effective in
preventing rise in
HR and MAP.
Esmolol may prove
more efficacious
than alternative
treatments.
Level of Evidence:
B- RCT
Strengths
-RCT
-P value provided
-Method of
randomization
mentioned with
method of
blindness
Weaknesses
-No detailed results
about heart rate or
blood pressure
values other than
graph images.
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Gupta, S. and
Tank, P.
(2011)
A
Comparative
Study of
Efficacy of
Esmolol and
Fentanyl for
Pressure
Attenuation
During
Laryngoscop
y and
Endotracheal
Intubation

To compare
the effect of
esmolol and
fentanyl in
preventing
hemodynami
c response to
laryngoscopy
and
endotracheal
intubation.

-90 pts
-Ages 15-55
-ASA grade I/II
-Gen. Surg., OGBYN,
ENT, Ortho cases
-R/O criteria:
expected difficult
intubation, HTN,
ischemic heart
disease, HR <60 bpm,
systolic > 100 mmHg,
COPD, prescribed
cardiac medications at
home
-Gujarat, India
-No statistically sig.
difference between
age/gender/weight
observed

RCT
Three groups:
Esmolol 2 mg/kg,
Fentanyl 2 mcg/kg,
and Control, normal
saline)
All 90 pts
premedicated with
0.2 mg
glycopyrrolate 10
min prior to
surgery.
Study drug
administered 3 min.
prior to intubation.
Induction included
thiopentone sodium
(5 mg/kg) and
succinylcholine (1.5
mg/kg).
Pulse, SpO2, NIBP,
ECG recorded
before
premedication and
after intubation, at
1,3,5,15,30,45,60,7
5,90 minutes and
postoperatively.

IDV1: Normal Saline
administration
IDV2: Esmolol 2
mg/kg administration
IDV3: Fentanyl 2
mcg/kg administration
DV1: HR
DV2: NIBP
DV3: RPP
Paired t test was used
for comparison. P<0.05
considered statistically
significant.

Esmolol had no
significant rise
in HR at any
time up
(P<0.001),
compared to
fentanyl and
control.
All three
groups had
increased SBP,
DBP, MAP, but
less observed in
Esmolol group.
RPP increase
was
insignificant in
Group E but
was observed
in E and F
(p<0.001).

Conclusion:
Both esmolol and
fentanyl are
successful in
treating the
hemodynamic
response to
intubation, with
esmolol proving
slightly more
efficacious.
Esmolol or
fentanyl may be
considered to
prevent
hemodynamic
response.
Level of Evidence:
B, single RCT
Strengths:
-RCT
-Observe
additional
measures such as
RPP.
-Diligent recording
of vital signs at
regular intervals
Weaknesses:
-No explained
randomization
method.
-Does not describe
if data recorder
blind to
medications
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Lyon et al.,
(2014)
A qualitative
study
assessing the
barriers to
implementati
on of
enhanced
recovery
after surgery.

Prakash et
al., (2019)
Attenuation
of

Identify
barriers to
implementati
on of newly
developed
ERAS
protocol
among
healthcare
employees

-18 stakeholders
identified and
participated in
interviews.
-Included nursing
staff from bedside
nurses to nurse
managers.

-Questioned using
developed semistructured interview
questionnaire.
-Interviews
conducted in person
- Questions in
interview focused
on aspects and
views of the ERAS
program.

-Data collected and
analyzed using
grounded theory
methodology
-Stages of data analysis
include codes,
concepts, categories
and theories to capture
categories, identify
relationships and
present appropriate
data.

To compare
the effects of
esmolol,
fentanyl, and
lidocaine in

ENT, Orthopedic,
gynecological,
general surgical,
neurological and

Prospective double
blind RCT
Groups:
Esmolol 2 mg/kg
Fentanyl 2 mcg/kg

IDV1: Esmolol 2
mg/kg
IDV2: Fentanyl 2
mcg/kg
DV1: SBP

administered.
-Unsure if blood
pressures are NIBP
or arterial.
-Unaware of
financial impact
based upon
medication chosen.
-Includes ages less
than 18 y.o.
Factors
Conclusion:
effecting use of -Barriers need to
new ERAS
be addressed in
protocol
order to optimize
include patient- multimodal
related factors, program of patient
practice related care.
factors,
-Barriers include
resources, and
staff perception,
staff-related
belief and need for
factors.
additional
education.
Staff related
Level of Evidence:
factors included -Level 6, single
difficulty
qualitative design
changing
Weaknesses
attitudes and
-Does not involve
beliefs, and a
anesthesia practice
need for
or specifically
additional staff narcotic sparing
education.
techniques.
Heart rate,
Conclusion:
SBP, DBP, and - Esmolol is more
MAP lower in
effective than
esmolol group
fentanyl
than fentanyl
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Cardiovascul
ar Responses
to
Laryngoscop
y and
Intubation: A
comparative
Study
between i.v.
Esmolol
hydrochlorid
e and
fentanyl
citrate

preventing
tachycardia
and
hypertension
in response
to
endotracheal
intubation
and
laryngoscopy
.

Schmitt, L.
(2019)

To identify if
education to
CRNA’s
improves
non-opioid
alternative
administratio
n rates and
identify
barriers to
use.

An
Educational
Intervention
for CRNA’s
on the Use of
Non-Opioid
Analgesics in
the
Gynecologic
al
Population:
A
Retrospectiv
e Chart
Review and

laparoscopic
procedures.
Conformed to
Helsinki declaration
ASA I/II
60 pts
20-50 y.o.
Mallampati I
Exclusion: unwilling,
emergency surgeries,
anticipated difficult
airway, ASA III or
higher, cardiovascular
disease, prescribed
beta-blockers or
calcium channel
blockers, prolonged
intubation.
-New York Hospital
-13 CRNA’s
- In person
questioning.

3 minutes prior to
intubation.
NIBP, HR recorded
prior to intubation,
at intubation, and
1,3,5, and 10 minute
intervals post
intubation.

DV2: DBP
DV3: MAP
DV4: HR
Shapiro Wilk test
checked normality, ttest to determine
significant difference,
Chi-square test.

group 1, 3, 10
minute post
intubation.

-Researcher
conducted
retrospective chart
review observing
non-opioid
administration rates
pre/post education
using a data
collection tool

IDV1: Use of one or
more opioid sparing
technique

-Rate of nonopioid
administration
increased
following
education by
CRNA’s
(p=0.002)

-13 CRNA’s
questioned using
developed Likerscale survey

DV1: Use of one or
more opioid sparing
technique
Barriers to non-opioid
administration
techniques gathered via
qualitative tools

Level of Evidence:
B, single RCT
Strengths:
-RCT
Weaknesses:
-Does not state
method of
randomization

-Perceived
barriers include
cost, influence
from surgeon
and
anesthesiologist
.

Conclusion:
-Education is
effective in
prompting
anesthesia
providers to
consider alternative
opioid sparing
techniques
-Barriers exist that
must be identified
in practice.
Level of Evidence:
Mixed
methodology:
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Qualitative
Survey

Qualitative
analysis- Level 6
Retrospective
Cohort Chart
Review- Level 4
Strengths:
-Identifies common
goals and
objectives among
desired study
design

Ugur et al.,
(2007)
Effects of
Esmolol,
Lidocaine,
and Fentanyl
on
Haemodyna
mic
Responses to
Endotracheal
Intubation

To compare
the effects of
esmolol,
fentanyl, and
lidocaine in
preventing
tachycardia
and
hypertension
in response
to
endotracheal
intubation
and
laryngoscopy
.

-120 pts
-Ages 20-50
-ASA I/II
-Surgery requiring
general anesthesia and
endotracheal
intubation
-R/O Criteria: CV
disease, DM, COPD,
Renal failure, hepatic
failure, CV
medication history,
SBP <100 or >160
mmHg, DBP <50 or
>110 mmHg, HR <50
or >120 bpm.
-Aydin, Turkey

RCT, via
randomization chart
All pt’s
premedicated with
0.04 mg/kg
midazolam 30
minutes prior to
induction.
Pt’s randomized
into four groups:
Control group (C)
received dextrose
5%, Esmolol (E)
received 1.5 mg/kg
and fentanyl (F) 1
mcg/kg.
Induction
completed with 2.5
mg/kg and
vecuronium 0.1
mg/kg.

IDV1: Dextrose 5%
administration preinduction
IDV2: Esmolol 1.5
mg/kg administration
pre-induction
IDV3: Fentanyl 1
mcg/kg administration
pre-induction.
IDV4: Lidocaine 1.5
mg/kg administration
pre-induction.
DV1: HR
DV2: MAP
DV3: RPP
ANOVA and
Bonferroni tests
utilized (p<0.05
considered significant)

-Elevation in
heart rate
observed in all
groups except
esmolol group,
with heart rate
decrease
immediately
after intubation
and 1 minute
after intubation
(p<0.008)
-Elevation in
MAP was
lowest in the
fentanyl group.
-RPP of
esmolol group
was lower than
control and
lidocaine group
3 minutes after
intubation

Conclusion:
-Esmolol has a
successful effect at
preventing
tachycardia and
increased RPP
during
endotracheal
intubation.
Level of Evidence:
B, single RCT
Strengths:
-RCT
-Larger sample size
within study
compared to other
studies.
-Observe
additional
measures such as
RPP.
-MD recording
measures blind to
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-Intubation
performed on first
attempt.
-HR, MAP, and
RPP calculated
before induction
Measurements:
taken after
administration of
drugs, after
induction,
immediately after
intubation, 1, 3, 5,
7, and 10 minutes
after intubation.

Vaishnav &
Chaudhari,
(2015)
Attenuation
of
Cardiovascul
ar Responses
to
Laryngoscop
y and
intubation: A
Comparative
Study
between IV
Esmolol
Hydrochlorid

Determine if
significant
difference
exists
between
esmolol and
fentanyl in
preventing
hemodynami
c response
when 3
minutes prior
to induction
laryngoscopy
and
intubation.

100 pts
ASA I/II
18- 60 years old
Elective surgeries
requiring general
anesthesia and
endotracheal
intubation.
Mallampati grade I
R/O: allergies to
drugs, emergency
surgeries, anticipated
difficult airway, ASA
Grade III/IV,
cardiovascular/respira
tory disease,
endocrinal disorders,

-Anesthesiologist
recording data blind
to agent given.
Groups:
Esmolol 2 mg/kg
Fentanyl 2 mcg/kg
All administered 3
min prior to
intubation.
HR, SBP, DBP,
MAP recorded. RPP
calculated.
No specified
method of
randomization

IDV1: Esmolol
IDV2: Fentanyl
DV1: SBP
DV2: DBP
DV3: MAP
DV4: HR
DV5: RPP
Statistical analysis
completed by Chi
square test
Vitals recorded after
study drugs given, at
laryngoscopy and
intubation, and 1, 2, 3,
4, 5, and 10 minute
post intubation.

(p<0.008) and
less than
fentanyl at 10
minutes after
intubation
(p<0.008)

agents
administered.
-Different sample
location compared
to other studies.
Weaknesses:
-Mixed results:
esmolol does not
prove more
efficacious in all
vital signs over
fentanyl.
-Does not state
concealment
method.

Heart rate, SBP,
DBP and MAP
were recorded
at baseline,
immediately
following study
drug
administration,
and every
minute for the
first ten
minutes post
intubation.
Group E
demonstrated
a lower HR

Conclusion:
Esmolol is better at
attenuating rise in
HR, RPP than
fentanyl. No
significant
difference is
observed between
the two groups in
regard to BP other
than one minute
post intubation.
Level of Evidence:
B, single RCT
Strengths:
-RCT
-Clinical
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e and
Fentanyl
Citrate

Varma et al.,
(2015)
A
Comparative
Study of
Efficacy of
Esmolol and
Fentanyl for
Attenuation
of Intubation
Response
During
Laryngoscop
y

hyperthyroidism and
renal failure history,
prescribed betablockers, or
sympatholytic drugs,
laryngoscopy/intubati
on >30 seconds.

To compare
the success
of esmolol
and fentanyl
bolus
administratio
n in treating
the
hemodynami
c changes
associated
with
laryngoscopy
and
intubation.

-90 pts
-Ages 18-55
-ASA Grade I/II
-Elective surgery
requiring general
anesthesia and
endotracheal
intubation.
-R/O Criteria: HTN,
bronchospastic
disease, cardiac
history, anticipated
difficult airway, B
blocker history.
- Visakhapatnam,
India

-RCT
-Pt’s randomized
into three groups:
Control group (C),
Esmolol (E) 2
mg/kg group, and
Fentanyl (F) 2
mcg/kg group.
-All premedicated
with glycopyrrolate
0.2 mg IV 30 min
prior to induction
-Study drug
administered 3
minutes prior to
laryngoscopy.

IDV1: Esmolol 2
mg/kg administration
pre-induction
IDV2: Fentanyl 2
mcg/kg administration
pre-induction.
DV1: HR
DV2: NIBP
Measurements
compared using
unpaired t test.
Multiple group
comparison done by
ANOVA.

than Group F
from one to
five minutes
(p=0.0001),
and a lower
SBP than Group
F at one minute
(p<0.05)
following
intubation.
Rate pressure
product was
lower (p<0.05)
among Group E
throughout all
ten minutes
following
intubation.
-Esmolol
prevented
increased heart
rate when
compared to
fentanyl
administration
at 1, 3 and 5
minutes after
intubation
(p<0.001)
-SBP increased
less with
esmolol (6.2%)
when compared
to fentanyl

observation of
MAP, SBP, DBP
in relation to
medication
administration and
efficacy
-Background on
medications
provided
-Clear charts and
data
Weakness
-No specified
manner of how
randomization
occurred.
Conclusion:
Esmolol prevented
significant
hemodynamic
response to
endotracheal
intubation when
compared to
fentanyl
administration.
May consider
utilizing esmolol to
attenuate
hemodynamic
response over
narcotic
administration.
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-No significant
difference between
demographics among
the three groups

-Induction
medications for all
participants:
thiopentone 5
mg/kg and
succinylcholine 2
mg/kg.
Measurements:
taken pre-induction,
1-minute post
induction, 1, 3, 5
and 10 minutes after
intubation.

(12.9%)
(p<0.01)

Level of Evidence:
B, single RCT
Strengths:
-RCT
-Clinical
observation of
MAP, SBP, DBP
in relation to
medication
administration and
efficacy
-Clinically feasible,
no side effects
observed with
esmolol
administration.
Weaknesses:
-No specific
statement on total
volume of LR
administration.
May alter results
-Does not address
financial
implications of one
medication choice
over another.
-Specific providers
may be
uncomfortable with
esmolol
administration over
fentanyl
administration
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Velasco et
al., (2019)

Identify
perceptions,
barriers and
facilitators of
CRNA’s to
adopt
alternatives
to opioids
intraoperativ
ely

-112 study
participants
-At least three years’
experience as a
CRNA
-Participants were
employed in Chicago,
Illinois hospitals
-SRNA’s and
CRNA’s with less
than three years’
experience were not
included for
questioning.

-Qualitative
interview
-Interview guide
developed based
upon a published
interview guide by
Lyon et al. (2014)
-Interview questions
were open ended,
and occurred over
the phone
-Questions observed
current opioid
alternative
strategies,
background with
early recovery after
surgery (ERAS)
protocols and
perceived barriers
and facilitators to
this practice.
-Qualitative results
analyzed

Qualitative analysis via
thematic analysis.

Common theme
barriers to nonnarcotic
administration:
belief in opioid
superiority,
inconsistent
analgesic
effects of
opioid
alternatives,
limited
experience with
alternatives,
limited
resources,
negative
experiences and
patient
comorbidities.

Conclusion
-Clear barriers and
facilitators exist
among practicing
CRNA’s
-Advanced
education is needed
to support nonnarcotic
alternatives in
practice.
Level of Evidence:
-Level 6, single
qualitative design

Strengths:
-Identifies clear
strengths and
weaknesses with
Common theme program
facilitators to
implementation of
non-narcotic
study
administration: Weaknesses:
Adverse effects -Does not include
of opioids,
new graduates who
institutional
may be familiar
policy/procedur with newer nones, positive
narcotic
experiences and alternatives
regional
-Qualitative study
anesthesia
superiority
belief.
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Appendix A
Smart Workplan
Project Goals: The overall goal is to improve anesthesia provider perception and familiarity of esmolol administration for attenuation
of hemodynamic responses to laryngoscopy and endotracheal intubation.
*SMART Objective

Activities

Projected
Completion
Date

Projected
Number of
People Reached

Organization(s)/
Partner(s)
collaborating with
to conduct activity

Submit application for
IR approval through
identified IRB board

-Review developed proposal
with faculty of record for
completion and satisfaction
with submission

October
2020

6

Stakeholders
identified through
site of
implementation,
DNP FOR, IRB
through
implementation site

-Complete IRB protocol and
submission
Meet with stakeholders
and FOR to review
content to be used for
development of pre/post
surveys and educational
in-service

-Review RCT’s and
recommendations to develop
educational in-service
-Identify additional
stakeholders appropriate for
in-service development (i.e.
pharmacy staff, IT)
-Utilization of Kotter’s
Change Model and Stetler
Model of Evidence-Based

October,
November
2020

10

Stakeholders,
additional staff
appropriate for
educational inservice development,
DNP FOR

Evaluation Plan (Describe
measures used to assess
satisfaction, project
outcomes, benefits of
activities, etc.)
Consider recommendations
and input from stakeholders
and FOR regarding proposal
Satisfaction of proposal
achieved by approval from
IRB in October of 2020.
Identify detailed educational
content to be used for inservice development
Assists initial stages of
educational development
Satisfaction of objective
assessed through FOR
feedback on developed
content.
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practice to develop tools for
use
Finalize pre/post
education surveys and
educational in-service
with FOR and
stakeholder approval

-In collaboration with FOR
and stakeholders, completion
of pre/post surveys and
educational in-service
content.

October,
November
2020

10

Stakeholders,
Additional staff
appropriate for
educational inservice development,
DNP FOR

Finalizing tools for education
and pre/post survey
information.

10

Stakeholders, DNP
FOR, All CRNA’s
and
Anesthesiologists
employed at
implementation site.

Specific days identified and
scheduled for education.

*Number
dependent upon
total number of
staff within

Stakeholders, DNP
FOR, All CRNA’s
and
Anesthesiologists

Gather pre/post-education
surveys from all staff in
attendance

Determine future dates of
education implementation.

-This will include
PowerPoint presentation for
education and Likert-scale
surveys, either provided via
email or printed
-Utilize tools to optimize
educational content for
healthcare providers

Identify dates of
opportunity for
educational in-service

Complete pre-survey
education.

-Identify dates of educational
in-service to be completed
with stakeholders
-Convene with stakeholder
November
and implementation site staff 2020
to determine official days for
educational in-service

-Successful completion of
pre-education surveys

December
2020,
January 2021
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Implement educational
in-service to anesthesia
providers.
Complete post-survey
education.

-In person education
occurring on previously
specified dates.

Compile pre/post-survey
results

-Compile paper and/or
electrical survey responses

Audit of Esmolol use 3
months pre/post
education
Data analysis of pre/post
education surveys and
audit of esmolol

anesthesia
department at
time of project
implementation

employed at
implementation site.

Observe staff attendance to
in-service sessions.

January,
February
2021

* Dependent
upon total
number of staff
within anesthesia
department at
time of project
implementation

Stakeholders, DNP
FOR, All CRNA’s
and
Anesthesiologists
employed at
implementation site.

Utilize Qualtrics software
and paper Likert scale
responses to identify degree
of familiarity and perception
of esmolol use.

May 2021

5

Stakeholders, IT
support staff, DNP
FOR

Gathered data of rate of
esmolol administration in
determined timeframe.

May 2021

5

Stakeholders, IT
support staff, DNP
FOR, WVU
Statistician

Appropriate data analysis of
findings.

-Successful completion of
post-education surveys

-Compile all responses to
determine degree of
familiarity and perception of
esmolol use pre/post
education
-Audit of rate of esmolol
administration within cases
prior to laryngoscopy and
endotracheal intubation.
-Data analysis to describe
findings from surveys and
audit
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Completion of data
-Complete analysis of
analysis and DNP project discovered data
-Write final DNP project
paper

July 2021

4

Stakeholders, DNP
FOR, WVU
Statistician

Improved familiarity,
perception and
administration rate of
esmolol
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Appendix B
Budget Plan Form with Justification
Budget Categories
ADMINISTRATIVE COSTS

Personal Funds
$0

Organizational
Contributions
$0

Administrative Justification: No administrative costs associated.
$0
$0
MARKETING
Marketing Justification: No marketing required for project implementation. Knowledge of
in-service will be provided to staff by chief CRNA and M.D.
EDUCATIONAL MATERIALS/
$0
$0
INCENTIVES
Educational Materials/Incentives Justification: Educational material will be developed using
free publicly accessible resources. Implementation will have no associated cost.
HOSPITALITY (food, room rentals, $100
$0
etc.)
Hospitality Justification: Breakfast will be provided to staff during these departmental
meetings to promote attendance and express thanks for allowing education to occur.
PROJECT SUPPLIES (office
$25
$0
supplies, postage, printing, etc.)
Project Supplies Justification: Majority of supplies for education and surveys development
are electronic. Paper surveys will be offered for in-person completion. Supplies include
printer paper, and ink.
$0
$0
TRAVEL EXPENSES
Travel Expenses Justification: No travel expenses associated since this is a local project.
OTHER
Other Justification:

$0

$0

TOTALS

$125

$0
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Appendix D
Evaluation Plan

Aim(s)

Outcomes

Implement an
informative inservice for
anesthesia
providers
about esmolol
as a nonnarcotic
alternative for
attenuating
hemodynamic
response to
intubation and
laryngoscopy

Increased use of
esmolol within the
specific clinical setting
of laryngoscopy and
endotracheal
intubation.

Objective/Criteria, AEB

Anesthesia providers
independently decide
medications administered
within particular setting.
Audit will take place
observing instances of
esmolol administration prior
to laryngoscopy and
endotracheal intubation.

Target
Population

What Data to
Collect

Collection
Methods

Anesthesia
providers
within chosen
facility

Number of
instances
esmolol was
administered
prior to
laryngoscopy
and ET
intubation,
rather than
fentanyl

Anonymous
audit of
patient
charts with
assistance
from IT.
Audit will
include 3
months of
cases preeducation
compared to
3 months
following
education

Data Analysis

Quantitative analysis using
descriptive statistics and paired
t-test including total number of
cases pre-education using
esmolol prior to intubation three
months prior and three months
following informative in-service
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Aim(s)

Outcomes

Objective/Criteria, AEB

Implement an
informative inservice for
anesthesia
providers about
esmolol as a nonnarcotic alternative
for attenuating
hemodynamic
response to
intubation and
laryngoscopy

Improved provider
perception and
familiarity with
esmolol
administration as an
acceptable
alternative

Outcomes will be measured
comparing Likert-scale
results on pre/post
education surveys

Target
Population

What Data to
Collect

Collection
Methods

Data Analysis

Anesthesia
providers
within
chosen
facility

Results from
Likert-scale
pre/post
informative inservice.
Responses will
be assigned
ordinal values

Paper
surveys
completed
by
individual
anesthesia
providers

Quantitative analysis using
descriptive statistics, and Wilcoxon
signed-rank test to determine
statistically significant finding
pre/post education administration,
and grounded theory approach for
open response question.
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Appendix E
Pre/Post-Education Survey
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Appendix F
Cover Letter

Dear Participant,
This letter is a request for you to take part in a research project titled “An Anesthesia-Based Quality
Improvement Initiative to Decrease Opioid Administration via Esmolol Administration. This project is
being conducted by Fredrick Hanna, BSN, SRNA in the DNP Nurse Anesthetist Program at WVU under
the supervision of Dr. Mike Frame, DMPNA, APRN, CRNA, the program’s Assistant Director, to fulfill
requirements for Doctoral Degree research.
If you decide to participate, you will be asked to attend an educational in-service regarding esmolol use to
attenuate the hemodynamic response to laryngoscopy and endotracheal intubation in comparison to
fentanyl administration. The in-service will begin and end with a survey to be completed by participants.
The survey will consist of a total of ten questions: seven Likert-scale ranking responses, two multiple
choice, and one open-text response. Surveys will be available via an online attachment or hard copy if
preferred. Following completion of the post education survey, participants will have no further
requirements for inclusion within this study. Your participation in this project will include attendance of
the educational in-service to be offered to the entirety of the anesthesia department at Mon Health
Medical Center. This in-service will be offered one time and aim to take no longer than 30 minutes for
completion. You must be 18 years of age or older to participate.
Your involvement in this project will be kept as confidential as legally possible. All data will be reported
in the aggregate. If the participants elect to be in attendance for the educational in-service, their
anonymity will be preserved, as no roster is being employed to identify participants in attendance.
Surveys completed via the online format will be gathered using Qualtrics Software and compiled void of
any identifying information to the person completing the survey including no name, or IP address. Hard
copy surveys will be completed void of identifying information and gathered in a lockbox once completed
at the conclusion of the attended in-service. Your participation is completely voluntary. You may skip any
question that you do not wish to answer, and you may discontinue at any time. West Virginia University's
Institutional Review Board approval of this project is on file.
If you have any questions about this research project, please feel free to contact me at (304)549-4999 or
by e-mail at hannafr@mix.wvu.edu. If you have any questions about your rights as a research participant,
please contact the WVU Office of Human Research Protection by phone at (304)293-7073 or by email at
IRB@mail.wvu.edu.
I hope that you will participate in this research project, as it could help us better understand current
evidence based-practice recommendations for esmolol use in attenuating the hemodynamic response to
laryngoscopy and intubation, as well as barriers and facilitators to using esmolol within practice. Thank
you for your time and consideration.
Sincerely,

Fredrick Hanna
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Appendix G
Retrospective Audit Data Collection Tool

Date of Audit: ___________ Auditor(s): ________________
De-identifying
chart number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Endotracheal intubation performed
(Y/N)

Esmolol administered prior to
laryngoscopy and intubation
(Y/N)
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Appendix H
Personal Communication Regarding HIPAA Waiver
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Appendix I
Corrected Timeline of Events

1

Appendix J
Pre/Post- Survey Comparison

Question 1: I am familiar with the use of esmolol for attenuating the hemodynamic response to
laryngoscopy and intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
2
3
1
7
3
3.37

Post Education
0
0
0
10
6
4.38

p-value

0.009

Question 2: I consider esmolol an appropriate alternative to fentanyl for use to attenuate the
hemodynamic response to laryngoscopy and intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
0
0
7
7
2
3.69

Post Education
0
0
1
7
8
4.44

p-value

0.008

Question 3: I am reluctant to administer esmolol for attenuating the hemodynamic response to
laryngoscopy and intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
2
8
3
3
0
2.44

Post Education
7
6
2
1
0
1.81

p-value

0.093

2

Question 4: Fentanyl provides a greater efficacy than esmolol in attenuating the hemodynamic
response to laryngoscopy and intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
1
0
10
5
0
3.33

Post Education
3
8
4
1
0
2.19

p-value

0.004

Question 5: Esmolol administration is associated with a greater risk for adverse outcomes
compared to fentanyl when given for attenuating the hemodynamic response to laryngoscopy and
intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
1
7
7
1
0
2.50

Post Education
2
11
1
2
0
2.19

p-value

0.265

Question 6: Additional resources are needed within my institution regarding the use of esmolol
for attenuation of the hemodynamic response to laryngoscopy and intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
0
0
4
10
2
3.88

Post Education
1
6
3
6
0
2.81

p-value

0.009

3
Question 7: Substantial barriers exist to esmolol use within the setting of laryngoscopy and
intubation.
Responses
Strongly Disagree
Disagree
Neither Agree nor Disagree
Agree
Strongly Agree
Mean

Pre-Education
0
6
4
6
0
3.00

Post Education
0
10
3
3
0
2.56

p-value

0.068

Question 8: The recommended dose of esmolol prior to laryngoscopy and endotracheal
intubation is?
Response
Incorrect
Correct
Mean

Pre-Education
10
6
0.625

Post-Education
0
16
1.0

p-value

0.009

Question 9: Esmolol is proven effective in preventing what hemodynamic considerations
following intubation?
Response
Incorrect
Correct
Mean

Pre-Education
10
6
0.625

Post-Education
2
14
0.875

p-value

0.041

Question 10: Please offer any concerns or remarks as well as any perceived barriers about the
use of esmolol for attenuating the hemodynamic response to laryngoscopy and intubation.
Responses

M.D.A. hesitancy
to change practice

Further education
required

Concern for adverse outcomes
with esmolol (i.e. bradycardia)

Work culture
supports fentanyl
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Appendix K
Esmolol Audit Results

Audit
Pre-education
Post-education

Instances Intubation
Required & Esmolol
Administered
44
45

Esmolol Administered
Prior to Laryngoscopy

p-value

0
1

0.16

